EatA mediated degradation of intestinal mucus is species-specific and driven by MUC2 structural features

S Sergio Trillo-Muyo (Department of Medical Biochemistry and Cell Biology, University of Gothenburg) B Brendan Dolan (Department of Medical Biochemistry and Cell Biology, University of Gothenburg) F Frida Svensson T Tim J. Vickers (Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine) L Liisa Arike M Maria-Jose García-Bonete J Jenny K. Gustafsson M Mathias I. Nielsen H Hans H. Wandall J James M. Fleckenstein (Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine) G Gunnar C. Hansson S Sjoerd van der Post (Department of Medical Biochemistry and Cell Biology, University of Gothenburg)

Abstract

Abstract Enterotoxigenic Escherichia coli (ETEC) infections are a leading cause of diarrheal illness, responsible for an estimated 100,000 deaths annually. ETEC pathogenesis is driven by various virulence factors, including toxins, adhesins, and noncanonical factors such as the protease EatA. The first line of host defense against intestinal pathogenic bacterial infections is the protective intestinal mucus layer. Here, we demonstrate the mechanism by which EatA degrades the core mucus component MUC2, thereby facilitating access to the epithelial cell surface and promoting infection. We identify the specific cleavage site region localized at the C-terminal of MUC2. EatA’s protease activity depends on the interaction between two distinct, uniquely spaced domains in human MUC2, which defines species specificity. We confirm this using a novel transgenic mouse model exclusively expressing human MUC2, which allows us to study the role of the mucus layer in the infection by human intestinal pathogens. These findings highlight how ETEC is adapted to specifically degrade the mucus layer of its human host.

Article Details

Volume / Issue Vol. 17, Issue 1
Published December 31, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (12)

S

Sergio Trillo-Muyo

Department of Medical Biochemistry and Cell Biology, University of Gothenburg

B

Brendan Dolan

Department of Medical Biochemistry and Cell Biology, University of Gothenburg

F

Frida Svensson

T

Tim J. Vickers

Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine

L

Liisa Arike

M

Maria-Jose García-Bonete

J

Jenny K. Gustafsson

M

Mathias I. Nielsen

H

Hans H. Wandall

J

James M. Fleckenstein

Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine

G

Gunnar C. Hansson

S

Sjoerd van der Post

Department of Medical Biochemistry and Cell Biology, University of Gothenburg